Ventripoint concludes successful execution of crucial quality assessments
Quest Diagnostics Passes Annual Audit Under Global Quality and Regulatory Standards
In a recent announcement provided by TheNewsWire via QuoteMedia, Quest Diagnostics, an industry leader in the application of AI to echocardiography, has successfully completed its annual audit under the Medical Device Single Audit Program (MDSAP), ISO 13485 Quality Management System, and EU Medical Device Regulation (MDR) requirements.
The audit, which ensured compliance with the medical device regulatory requirements of multiple jurisdictions, including the U.S. and Canada, resulted in zero major nonconformities for Quest Diagnostics. This significant achievement underscores the company's commitment to maintaining the highest standards of quality and regulatory compliance.
Quest's VMS products are powered by its proprietary Knowledge Based Reconstruction technology, making them versatile and compatible with all ultrasound systems from any vendor, supported by regulatory market approvals in the U.S., Europe, and Canada.
The successful audit under the European Union's MDR 2017/745 demonstrates that Quest's products meet the rigorous new regulatory standards governing medical devices in the European market. This achievement further cements the company's position as a trusted provider in the medical device industry.
The TSX Venture Exchange does not take responsibility for the accuracy of this news release. The forward-looking statements and information are based on certain key expectations and assumptions made by the Company. It is important to note that potential risks and uncertainties may impact these forward-looking statements and information.
Quest Diagnostics continues to comply with global quality and regulatory standards, including the globally recognized standard for quality management systems specific to the medical device industry, ISO 13485:2016.
The contact person for Quest Diagnostics is Hugh MacNaught, who can be reached at [email protected] or by phone at 604-671-4201.
This news release contains forward-looking statements and information. The copyright for this news release belongs to TheNewswire. The Company undertakes no obligation to update publicly or revise any forward-looking statements or information, unless so required by applicable securities laws.
Read also:
- Trump's SNAP reductions and New York City Council's grocery delivery legislation: Problems for city residents highlighted
- Reducing dental expenses for elderlies in Sweden: Over 50% cut in charges for pensioners by the government
- Forty-year-old diet: A list of meal choices to savor
- Exiled Life's Conundrum: A Blend of Liberation, Disillusionment, and Distress
